Assessment of Sarcopenia and Obesity in Patients with Myasthenia Gravis Using Dual-Energy X-ray Absorptiometry: A Cross-Sectional Study
Sarcopenia and obesity can negatively impact quality of life and cause chronic fragility, and are associated with neuromuscular diseases, including myasthenia gravis (MG). The long-term consequences of body composition changes in chronic MG remain unknown; we therefore evaluated changes in body comp...
Enregistré dans:
Auteurs principaux: | Che-Cheng Chang, Yen-Kung Chen, Hou-Chang Chiu, Jiann-Horng Yeh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f60eb21ff1a241eaa5cf4b44d9d40dc6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fetal Surveillance in Pregnancies with Myasthenia Gravis
par: Brîndușa Ana Cimpoca-Raptis, et autres
Publié: (2021) -
The risk of sarcopenia 24 months after bariatric surgery – assessment by dual energy X-ray absorptiometry (DEXA):
a prospective study
par: Matej Pekař, et autres
Publié: (2020) -
Research of antibodies to the acetylcholine receptors in patients with myasthenia gravis
par: T. V. Romanova
Publié: (2013) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
par: Maryam Abbas, et autres
Publié: (2021) -
A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics
par: Virginia M. Smith, et autres
Publié: (2021)